These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 21672318)
1. A method of utrophin up-regulation through RNAi-mediated knockdown of the transcription factor EN1. Wang Q; Cao DH; Jin CL; Lin CK; Ma HW; Wu YY J Int Med Res; 2011; 39(1):161-71. PubMed ID: 21672318 [TBL] [Abstract][Full Text] [Related]
3. The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy. Perkins KJ; Burton EA; Davies KE Nucleic Acids Res; 2001 Dec; 29(23):4843-50. PubMed ID: 11726694 [TBL] [Abstract][Full Text] [Related]
4. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains. van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942 [TBL] [Abstract][Full Text] [Related]
5. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine. Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725 [TBL] [Abstract][Full Text] [Related]
6. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Miura P; Jasmin BJ Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393 [TBL] [Abstract][Full Text] [Related]
7. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Burton EA; Tinsley JM; Holzfeind PJ; Rodrigues NR; Davies KE Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14025-30. PubMed ID: 10570192 [TBL] [Abstract][Full Text] [Related]
8. [The regulation of UTROPHIN expression by EN1]. Wang Q; Cao DH; Lin CK; Wang ZD; Cui WT; Jin CL Yi Chuan; 2011 Apr; 33(4):347-52. PubMed ID: 21482524 [TBL] [Abstract][Full Text] [Related]
10. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle. Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831 [TBL] [Abstract][Full Text] [Related]
11. Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics. Amirouche A; Tadesse H; Lunde JA; Bélanger G; Côté J; Jasmin BJ Hum Mol Genet; 2013 Aug; 22(15):3093-111. PubMed ID: 23575223 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of utrophin-A and -B promoters in the central nervous system (CNS) of normal and dystrophic mdx mice. Baby SM; Bogdanovich S; Willmann G; Basu U; Lozynska O; Khurana TS Brain Pathol; 2010 Mar; 20(2):323-42. PubMed ID: 19486009 [TBL] [Abstract][Full Text] [Related]
13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
14. UtroUp is a novel six zinc finger artificial transcription factor that recognises 18 base pairs of the utrophin promoter and efficiently drives utrophin upregulation. Onori A; Pisani C; Strimpakos G; Monaco L; Mattei E; Passananti C; Corbi N BMC Mol Biol; 2013 Jan; 14():3. PubMed ID: 23363418 [TBL] [Abstract][Full Text] [Related]
16. Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1/2 inhibition. Gleneadie HJ; Fernandez-Ruiz B; Sardini A; Van de Pette M; Dimond A; Prinjha RK; McGinty J; French PMW; Bagci H; Merkenschlager M; Fisher AG Commun Biol; 2023 Mar; 6(1):318. PubMed ID: 36966198 [TBL] [Abstract][Full Text] [Related]
17. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy. D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice. Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141 [TBL] [Abstract][Full Text] [Related]